WebJonathan Wu is a Pipeline Strategy Senior Director, Corporate Development at Cytomx Therapeutics based in South San Francisco, California. Previou sly, Jonathan was a Senior Analyst at Edwards Lifesciences and also held positions at Pfizer, Zhuhai Kairui Biotech, Johnson & Johnson, Catalyst Biosciences, Curia, BeiGene, Amgen, AA Chempharm, ... WebGet the latest CytomX Therapeutics Inc (CTMX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
CytomX Therapeutics Inc (CTMX) Stock Price & News
WebJul 13, 2024 · CytomX is maintaining its robust research, translational, and early development organizations to support ongoing internal pipeline efforts with two … WebFeb 24, 2024 · CytomX management will host a conference call today at 5:00 p.m. ET (2:00 p.m. PT). Interested parties may access the live webcast of the conference call from the Events and Presentations page of CytomX's website at www.cytomx.com or by dialing 1-877-809-6037 (U.S. and Canada) or 1-615-247 flip up dj headphones
Amgen And CytomX Therapeutics Announce Strategic Collaboration In ...
WebMar 27, 2024 · SOUTH SAN FRANCISCO, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, today reported... WebDec 22, 2024 · CytomX is a clinical-stage, oncology-focused biopharmaceutical company dedicated to destroying cancer differently. By pioneering a novel class of conditionally activated biologics, powered by its... WebCytomX is a different kind of clinical-stage biopharmaceutical company – intent on revolutionizing the way we treat cancer. Our distinctive Probody ® therapeutics are … CytomX and AbbVie are co-developing CX-2029, a conditionally activated antibody … CytomX embraces and acknowledges the importance of diversity and seeks to … The Investor Relations website contains information about CytomX Therapeutics, … SOUTH SAN FRANCISCO, Calif. , March 22, 2024 (GLOBE NEWSWIRE) -- … The Investor Relations website contains information about CytomX Therapeutics, … CytomX Therapeutics, Inc. 151 Oyster Point Blvd Suite 400 South San Francisco, CA … Dr. McCarthy joined CytomX in 2010 as the chief business officer, served as the … Designed to selectively activate in the presence of cancer. Probody ® … CytomX is leading early development and has advanced CX-904 into a Phase 1/1b … CytomX’s clinical pipeline also includes cancer immunotherapeutic candidates … flip up deck mower